457 related articles for article (PubMed ID: 11967018)
1. Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction.
Nagatoya K; Moriyama T; Kawada N; Takeji M; Oseto S; Murozono T; Ando A; Imai E; Hori M
Kidney Int; 2002 May; 61(5):1684-95. PubMed ID: 11967018
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstruction.
Baba I; Egi Y; Utsumi H; Kakimoto T; Suzuki K
Mol Med Rep; 2015 Dec; 12(6):8010-20. PubMed ID: 26498136
[TBL] [Abstract][Full Text] [Related]
3. The Rho-ROCK system as a new therapeutic target for preventing interstitial fibrosis.
Moriyama T; Nagatoya K
Drug News Perspect; 2004; 17(1):29-34. PubMed ID: 14993932
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of a combination of Rho-kinase inhibitor and ACE inhibitor on tubulointerstitial fibrosis induced by unilateral ureteral obstruction.
Takeda Y; Nishikimi T; Akimoto K; Matsuoka H; Ishimitsu T
Hypertens Res; 2010 Sep; 33(9):965-73. PubMed ID: 20664550
[TBL] [Abstract][Full Text] [Related]
5. Rho kinase inhibitors block activation of pancreatic stellate cells.
Masamune A; Kikuta K; Satoh M; Satoh K; Shimosegawa T
Br J Pharmacol; 2003 Dec; 140(7):1292-302. PubMed ID: 14581180
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of Y-27632 on chronic allograft nephropathy in rats.
Liu M; Gu M; Wu Y; Zhu P; Zhang W; Yin C; Zhang WJ
J Surg Res; 2009 Nov; 157(1):e117-27. PubMed ID: 19589538
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of HSP47 in the mouse kidneys with unilateral ureteral obstruction.
Moriyama T; Kawada N; Ando A; Yamauchi A; Horio M; Nagata K; Imai E; Hori M
Kidney Int; 1998 Jul; 54(1):110-9. PubMed ID: 9648069
[TBL] [Abstract][Full Text] [Related]
8. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction.
Vieira JM; Mantovani E; Rodrigues LT; Dellê H; Noronha IL; Fujihara CK; Zatz R
Nephrol Dial Transplant; 2005 Aug; 20(8):1582-91. PubMed ID: 15855201
[TBL] [Abstract][Full Text] [Related]
10. Signaling mechanism of renal fibrosis in unilateral ureteral obstructive kidney disease in ROCK1 knockout mice.
Fu P; Liu F; Su S; Wang W; Huang XR; Entman ML; Schwartz RJ; Wei L; Lan HY
J Am Soc Nephrol; 2006 Nov; 17(11):3105-14. PubMed ID: 17005937
[TBL] [Abstract][Full Text] [Related]
11. Concomitant inhibition of renin angiotensin system and Toll-like receptor 2 attenuates renal injury in unilateral ureteral obstructed mice.
Chung S; Jeong JY; Chang YK; Choi DE; Na KR; Lim BJ; Lee KW
Korean J Intern Med; 2016 Mar; 31(2):323-34. PubMed ID: 26932402
[TBL] [Abstract][Full Text] [Related]
12. Small guanosine triphospatase RhoA and Rho-associated kinase as regulators of trophoblast migration.
Shiokawa S; Iwashita M; Akimoto Y; Nagamatsu S; Sakai K; Hanashi H; Kabir-Salmani M; Nakamura Y; Uehata M; Yoshimura Y
J Clin Endocrinol Metab; 2002 Dec; 87(12):5808-16. PubMed ID: 12466390
[TBL] [Abstract][Full Text] [Related]
13. Fluvastatin suppresses oxidative stress and fibrosis in the interstitium of mouse kidneys with unilateral ureteral obstruction.
Moriyama T; Kawada N; Nagatoya K; Takeji M; Horio M; Ando A; Imai E; Hori M
Kidney Int; 2001 Jun; 59(6):2095-103. PubMed ID: 11380811
[TBL] [Abstract][Full Text] [Related]
14. LSKL, a peptide antagonist of thrombospondin-1, attenuates renal interstitial fibrosis in rats with unilateral ureteral obstruction.
Xie XS; Li FY; Liu HC; Deng Y; Li Z; Fan JM
Arch Pharm Res; 2010 Feb; 33(2):275-84. PubMed ID: 20195829
[TBL] [Abstract][Full Text] [Related]
15. Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis.
Hewitson TD; Mookerjee I; Masterson R; Zhao C; Tregear GW; Becker GJ; Samuel CS
Endocrinology; 2007 Feb; 148(2):660-9. PubMed ID: 17095590
[TBL] [Abstract][Full Text] [Related]
16. The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration.
Lepley D; Paik JH; Hla T; Ferrer F
Cancer Res; 2005 May; 65(9):3788-95. PubMed ID: 15867375
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of endotoxin-induced acute lung injury by the Rho-associated kinase inhibitor, Y-27632.
Tasaka S; Koh H; Yamada W; Shimizu M; Ogawa Y; Hasegawa N; Yamaguchi K; Ishii Y; Richer SE; Doerschuk CM; Ishizaka A
Am J Respir Cell Mol Biol; 2005 Jun; 32(6):504-10. PubMed ID: 15778497
[TBL] [Abstract][Full Text] [Related]
18. Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction.
Ma J; Nishimura H; Fogo A; Kon V; Inagami T; Ichikawa I
Kidney Int; 1998 Apr; 53(4):937-44. PubMed ID: 9551401
[TBL] [Abstract][Full Text] [Related]
19. A negative modulatory role for rho and rho-associated kinase signaling in delamination of neural crest cells.
Groysman M; Shoval I; Kalcheim C
Neural Dev; 2008 Oct; 3():27. PubMed ID: 18945340
[TBL] [Abstract][Full Text] [Related]
20. Rho guanosine 5'-triphosphatases differentially regulate insulin-like growth factor I (IGF-I) receptor-dependent and -independent actions of IGF-II on human trophoblast migration.
Shields SK; Nicola C; Chakraborty C
Endocrinology; 2007 Oct; 148(10):4906-17. PubMed ID: 17640993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
